| Project | Target | Classification | Indication | Discovery | Lead optimization | Pre-clinical | Phase 1/2/3 |
|---|---|---|---|---|---|---|---|
| OCG-01-0713 | VGLL1 | Peptide | Progressive gastric cancer, Triple negative breast cancer, Pancreatic cancer, Lung cancer |
 |
|||
| OCG-01-1564 | HIF-1 | Chemical | Liver cancer, Blood Cancer, Kidney cancer |
 |
|||
| OCG-01-2020 | SYT11 | ASO/PROTAC | Diffuse type gastric cancer, Colorectal cancer, Lung cancer |
 |
